Rating History for AN2 Therapeutics (ANTX) by TD Cowen

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/18/2024 Ritu Baral Downgrade Hold
(Buy)
N/A
(N/A)
1.00
(2.85)
185% Details